Francis Mégraud is an expert in Gastroenterology at University of Bordeaux (France). Francis Mégraud has authored 723 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 2,295 (community average: 125). How the SLR is computed.

LeadR Profile

Francis Mégraud University of Bordeaux France
2 295 ScienceLeadR Reputation 2295
Network Map

Gastroenterology

Subspecialties: Infectiology - Pharmacy - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1981 - 2026

Source: PubMed

University of Bordeaux

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 723

Citations

Citations: 51 485 1st author: 72 Last author: 166 Unique author: 63


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Higher Doses of Bismuth and Antibiotics Do Not Improve Helicobacter pylori Treatment Effectiveness: Results From the European Registry on Helicobacter pylori Management.
PMID 41935593 — levofloxacin, metronidazole, clarithromycin, amoxicillin, tetracycline, therapeutics
Clin Gastroenterol Hepatol20260
Helicobacter pylori Infection - Advances, Challenges, and the Road Ahead.
PMID 42906088 — helicobacter pylori, helicobacter, neoplasms, research, stomach neoplasms, infections
N Engl J Med Top journal20260
Management Strategies for Helicobacter pylori-Application of the Stewardship Principles.
PMID 42867262 — helicobacter pylori, clarithromycin, amoxicillin, helicobacter, proton pump inhibitors, therapeutics
Helicobacter20260
Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
PMID 42353655 — registries, helicobacter pylori, safety, clarithromycin, amoxicillin, helicobacter, therapeutics
Antibiotics (Basel)20262
Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.
PMID 42310251 — helicobacter pylori, helicobacter, antimicrobial stewardship, pharmacology, therapeutics, drug resistance
Aliment Pharmacol Ther20264

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 2
Phase 4 1

By status:

Completed 4
Recruiting 1

By type:

Interventional 4
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map